Hjem › Krampeanfald › Texas
Krampeanfald kliniske forsøg i Texas
14 studier for Krampeanfald søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Children's Health Specialty Center, Dallas
- UTHealth Houston, Houston
RekruttererFase 3
Alder 2 til 55 · Alle køn · Opdateret 2. okt. 2026 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Child Neurology & Consultants of Austin, Austin
- ANESC Research, El Paso
RekruttererFase 1
Alder 12 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Advanced Neurology Epilepsy and Sleep Center/ANESC Research, El Paso
- Stryde Research, Frisco
- UT Health Houston, Houston
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 1. okt. 2026 · NCT06798896Prospective Natural History Study of POLG Disease
- Baylor Hospital, Dallas
- UTHealth Houston, Houston
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 15. sep. 2026 · NCT07775872A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Child Neurology Consultants of Austin, Austin
RekruttererFase 3
Alder 2 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04462770Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Baylor College of Medicine, Houston
- University of Texas Health Science Center in Houston, Houston
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT07594119Mapping of Human Cognition
- The University of Texas Health Science Center at Houston, Houston
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 14. jul. 2026 · NCT05989893Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- UT Southwestern Medical Center, Dallas
- UTHealth Houston, Houston
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 9. jun. 2026 · NCT05135091A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Austin Epilepsy Care Center, Austin
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 14. maj 2026 · NCT05716100A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
- Baylor College of Medicine, Houston
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 23. jan. 2026 · NCT07219407Pharmacological Modulation of Brain Oscillations in Memory Processing
- University of Texas Southwestern Medical Center, Dallas
RekruttererTidlig fase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 55 · Alle køn · Opdateret 3. okt. 2025 · NCT05594017Pediatric Dose Optimization for Seizures in Emergency Medical Services
- University of Texas Southwestern, Dallas
- Baylor College of Medicine, Houston
RekruttererFase 3
6 Months – 13 Years · Alle køn · Opdateret 30. sep. 2025 · NCT05121324An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- Praxis Research Site, Round Rock
- Praxis Research Site, Seabrook
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 3. apr. 2025 · NCT06908356Epilepsy Learning Healthcare System (ELHS)
- UT Southwestern Children's Dallas, Dallas
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 30. aug. 2024 · NCT06265103Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.